[go: up one dir, main page]

FR2916974B1 - Procede de preparation de nanoparticules lipidiques - Google Patents

Procede de preparation de nanoparticules lipidiques

Info

Publication number
FR2916974B1
FR2916974B1 FR0755662A FR0755662A FR2916974B1 FR 2916974 B1 FR2916974 B1 FR 2916974B1 FR 0755662 A FR0755662 A FR 0755662A FR 0755662 A FR0755662 A FR 0755662A FR 2916974 B1 FR2916974 B1 FR 2916974B1
Authority
FR
France
Prior art keywords
preparation
lipid nanoparticles
nanoparticles
lipid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR0755662A
Other languages
English (en)
Other versions
FR2916974A1 (fr
Inventor
Patrick Saulnier
Jean Pierre Benoit
Nicolas Anton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite dAngers
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Universite dAngers
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite dAngers filed Critical Universite dAngers
Priority to FR0755662A priority Critical patent/FR2916974B1/fr
Priority to EP08805978A priority patent/EP2167054A2/fr
Priority to PCT/FR2008/051043 priority patent/WO2009004214A2/fr
Priority to US12/663,960 priority patent/US9005666B2/en
Priority to CA2690479A priority patent/CA2690479A1/fr
Publication of FR2916974A1 publication Critical patent/FR2916974A1/fr
Application granted granted Critical
Publication of FR2916974B1 publication Critical patent/FR2916974B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
FR0755662A 2007-06-11 2007-06-11 Procede de preparation de nanoparticules lipidiques Active FR2916974B1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR0755662A FR2916974B1 (fr) 2007-06-11 2007-06-11 Procede de preparation de nanoparticules lipidiques
EP08805978A EP2167054A2 (fr) 2007-06-11 2008-06-11 Procede de preparation de nanoparticules lipidiques
PCT/FR2008/051043 WO2009004214A2 (fr) 2007-06-11 2008-06-11 Procede de preparation de nanoparticules lipidiques
US12/663,960 US9005666B2 (en) 2007-06-11 2008-06-11 Process for preparing lipid nanoparticles
CA2690479A CA2690479A1 (fr) 2007-06-11 2008-06-11 Procede de preparation de nanoparticules lipidiques

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0755662A FR2916974B1 (fr) 2007-06-11 2007-06-11 Procede de preparation de nanoparticules lipidiques

Publications (2)

Publication Number Publication Date
FR2916974A1 FR2916974A1 (fr) 2008-12-12
FR2916974B1 true FR2916974B1 (fr) 2010-11-26

Family

ID=38996498

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0755662A Active FR2916974B1 (fr) 2007-06-11 2007-06-11 Procede de preparation de nanoparticules lipidiques

Country Status (5)

Country Link
US (1) US9005666B2 (fr)
EP (1) EP2167054A2 (fr)
CA (1) CA2690479A1 (fr)
FR (1) FR2916974B1 (fr)
WO (1) WO2009004214A2 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9393315B2 (en) 2011-06-08 2016-07-19 Nitto Denko Corporation Compounds for targeting drug delivery and enhancing siRNA activity
FR2916973B1 (fr) * 2007-06-11 2010-02-26 Univ Angers Nanocapsules a coeur lipidique chargees en actif(s) hydrosoluble(s) ou hydrodispersible(s)
FR2939699B1 (fr) * 2008-12-12 2011-05-06 Univ Angers Procede de preparation de nanoparticules lipidiques
FR2943544B1 (fr) 2009-03-31 2012-04-20 Univ Angers Procede de preparation de capsules lipidiques fonctionnalisees.
FR2950253B1 (fr) * 2009-09-24 2011-09-23 Ethypharm Sa Nanocapsules lipidiques, procede de preparation et utilisation comme medicament
WO2012059936A1 (fr) 2010-11-03 2012-05-10 Padma Venkitachalam Devarajan Compositions pharmaceutiques destinées à l'administration de médicaments colloïdaux
WO2012114201A1 (fr) 2011-02-25 2012-08-30 Aroma Technologies Nanoencapsulation d'huiles essentielles pour la prévention et la guérison des maladies infectieuses seules ou associées à un antibiotique
US10196637B2 (en) 2011-06-08 2019-02-05 Nitto Denko Corporation Retinoid-lipid drug carrier
IN2015DN00220A (fr) * 2012-06-29 2015-06-12 Archer Daniels Midland Co
US9693958B2 (en) 2013-03-15 2017-07-04 Cureport, Inc. Methods and devices for preparation of lipid nanoparticles
FR3017294B1 (fr) 2014-02-07 2021-10-01 Atlangram Nanoparticules lipidiques comprenant un antibiotique et leurs utilisations en therapie
FR3026009B1 (fr) * 2014-09-24 2018-01-26 Universite D'angers Nanocapsules lipidiques, compositions pharmaceutiques, procede de preparation, et utilisations correspondants
GB201721832D0 (en) * 2017-12-22 2018-02-07 Waterford Institute Of Tech Ocular drug delivery
WO2020021052A2 (fr) 2018-07-27 2020-01-30 INSERM (Institut National de la Santé et de la Recherche Médicale) Utilisation d'alcools terpéniques acycliques pour améliorer l'activité antimicrobienne de la colistine
EP3679928A1 (fr) 2019-01-08 2020-07-15 Atlangram Composition pharmaceutique de type gel pour traiter/prevenir une infection
US11504327B1 (en) 2019-01-21 2022-11-22 Eric Morrison Method of preparing nanoparticles by hot-melt extrusion
BR112021025859A2 (pt) * 2019-06-21 2022-03-03 Univ Catholique Louvain Nanocápsulas de lipídeo carregadas com miméticos de incretina
CN110437401B (zh) * 2019-06-25 2022-06-10 山东师范大学 基于微乳液模板法的COFs纳米晶体及制备方法与应用
WO2023236096A1 (fr) * 2022-06-08 2023-12-14 威海天原生物科技有限公司 Composition d'huile volatile végétale et son procédé de préparation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6241969B1 (en) * 1998-06-26 2001-06-05 Elan Corporation Plc Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
FR2805761B1 (fr) * 2000-03-02 2002-08-30 Mainelab Nanocapsules lipidiques, procede de preparation et utilisation comme medicament
FR2840532B1 (fr) 2002-06-11 2005-05-06 Ethypharm Sa Nanocapsules lipidiques furtives, procede de preparation et utilisation comme vecteur de principes(s) actif(s)
EP1955695A1 (fr) 2007-02-06 2008-08-13 Institut National De La Sante Et De La Recherche Medicale (Inserm) Nanocapsules de complexes lipophiles d'acides nucléiques

Also Published As

Publication number Publication date
EP2167054A2 (fr) 2010-03-31
WO2009004214A3 (fr) 2009-04-02
WO2009004214A2 (fr) 2009-01-08
FR2916974A1 (fr) 2008-12-12
CA2690479A1 (fr) 2009-01-08
US20100233275A1 (en) 2010-09-16
US9005666B2 (en) 2015-04-14

Similar Documents

Publication Publication Date Title
FR2916974B1 (fr) Procede de preparation de nanoparticules lipidiques
EP2401225A4 (fr) Approche supramoléculaire pour la préparation de nanoparticules à taille réglable
FR2911878B1 (fr) Procede de preparation de polyhydroxy-urethanes.
EP2162386A4 (fr) Procédé de formation de nanoparticules fonctionnalisées stables
EP2320919A4 (fr) Processus à grande échelle pour la préparation de thylacoïdes
FR2939699B1 (fr) Procede de preparation de nanoparticules lipidiques
ZA200905012B (en) Process for the preparation of certain substituted sulfimines
FR2943660B1 (fr) Procede d'elaboration de graphene
EP2212248A4 (fr) Procédé de préparation du graphène
FR2962731B1 (fr) Procede de preparation de derives d'amino-benzoyl-benzofurane
FR2958289B1 (fr) Procede de preparation de derives de 3-ceto-benzofurane
FR2947186B1 (fr) Procede de preparation d'une emulsion huile-dans-eau stable
FR2916435B1 (fr) Nouveau procede de preparation de la zolithe eu-1.
FR2960229B1 (fr) Procede de preparation de nanoparticules de bore
FR2958291B1 (fr) Procede de preparation de derives d'amino-benzofurane
FR2963006B1 (fr) Procede de preparation de derives de nitro-benzofurane
FR2958290B1 (fr) Procede de preparation de derives de sulfonamido-benzofurane
EP2551237A4 (fr) Procédé de préparation de nanoparticules
FR2923484B1 (fr) Procede de preparation de composes morphiniques
FR2939795B1 (fr) Procede de preparation d'esters actives
FR2966150B1 (fr) Procede de preparation de la 2-hydroxybutyrolactone
FR2918983B1 (fr) Procede de preparation de dinitrotoluene
FR2947265B1 (fr) Procede de preparation d'alkylalcanolamines
IL205082A0 (en) Process for the preparation of tetranorlabdane derivatives
FR2969616B1 (fr) Procede de preparation de complexes carbeniques de platine

Legal Events

Date Code Title Description
TQ Partial transmission of property

Owner name: UNIVERSITE D'ANGERS, FR

Effective date: 20130808

Owner name: INSERM, FR

Effective date: 20130808

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11